Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01767337 · ClinicalTrials.gov registry record · NA

Intracutaneous Delivery of Varied Dose Volumes of Saline

A NA study, sponsored by FluGen.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT01767337: Completed NA study, sponsored by FluGen.

NCT01767337 is a NA study that has completed, run by FluGen. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01767337, a NA study, has completed, sponsored by FluGen.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

This study will evaluate intracutaneous delivery of 0.1, 0.25 and 0.5 milliliter volumes of saline from the FLUGEN 101.2 investigational microneedle-based device.

Primary Outcome

Observe injection sites for change of appearance post-dose including initial wheal formation and subsequent resolution.

Interventions

  • DEVICE FLUGEN 101.2 device

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2012-12
Est. Completion 2012-12
Phase NA
FluGen

6 total trials

What the finished NCT01767337 record still lists

NCT01767337 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which FLUGEN 101.2 device is the first listed.

NCT01767337 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01767337 about?

NCT01767337 is a clinical study titled "Intracutaneous Delivery of Varied Dose Volumes of Saline". This study will evaluate intracutaneous delivery of 0.1, 0.25 and 0.5 milliliter volumes of saline from the FLUGEN 101.2 investigational microneedle-based device.

What is the current status of trial NCT01767337?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2012-12. Estimated completion is 2012-12.

What interventions are being tested in trial NCT01767337?

The interventions under investigation include: FLUGEN 101.2 device (DEVICE).

Who is sponsoring clinical trial NCT01767337?

This trial is sponsored by FluGen, which has 6 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01767337's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01767337, the US trial registry maintained by the National Library of Medicine. NCT01767337 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.